Atavistic Oncology: A New Dawn in Cancer Therapy

Atavistic Oncology, conceived in 2011 by Dr. Frank Arguello, represents a groundbreaking shift in cancer treatment and scientific understanding.

Following the publication of Dr. Arguello’s influential book, “Atavistic Metamorphosis: A New and Logical Explanation on the Origin and Biological Nature of Cancer Cells,” atavistic oncology has emerged as a leading approach in the fight against cancer.

This innovative field offers a new perspective on the true origin and biological behavior of cancer cells, leading to the development of atavistic chemotherapy.

Further, Atavistic Oncology Cancer treatment utilizes a unique combination of FDA-approved drugs to target and eliminate cancer cells selectively.

Atavistic chemotherapy stands out for its effectiveness and non-toxic nature, offering a home-based treatment option under the guidance of an oncologist or family doctor.

Unlike alternative cancer treatments, atavistic chemotherapy provides a scientifically validated method to eradicate primary, metastatic, and inoperable/unresectable cancers.

Clinical Trial Expectations

Patients eligible for the Atavistic Chemotherapy Clinical Trial can expect to see a significant clinical and/or radiological response within the first three weeks, with the potential for complete eradication of cancer within six months, or they owe nothing.

 

Don't Waste Your Life!

The Truth About Conventional Cancer Treatments

Our Patients' Cancers Before and After Atavistic Chemotherapy​

(Click Images to Enlarge)

This Work is Dedicated to the Loving
Memory of our Mother

If only the love of your young children could have saved you, you certainly would not have died. But our love and tears were not enough. I never understood why God took you so early from our lives, until now. This book would have never been written. Let’s hope this book and the subsequent work derived from these concepts prevent other families from experiencing the pain and sorrows that we went through with your premature death.

Address

U.S Administrative and Enrolment Office:

The Atavistic Chemotherapy Trial
Bethesda Metro Center
Bethesda, Maryland 20814

Call us:

Tel: 301 – 760 – 7777 (Maryland)

Fax: (301) 690 – 9000 (Maryland)

Clinical Trial Sites:

Dr. Frank Arguello (Medical Atavistic Oncology)
Dr. Salvador Belmont (Surgical Atavistic Oncology)
HOSPITAL LOS ANGELES
Av. Campos Eliseos 9371
Cd Juárez, Chih., 32472
Mexico

NEW PATIENTS INFO